Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.43
-0.02-1.38%
Last update: Oct 12, 7:58 PM
$1.50
0.053.45%
Cellectar Biosciences Inc (CLRB) Stock Price, Quote, News & History
CLRBNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Cellectar Biosciences has a consensus price target of $286.67.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $1.5 last updated October 12, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
